Ravi Rao

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

Ronald van Vollenhoven, Paul Emery, Clifton O. Bingham et al. · The Journal of Rheumatology · 2010 · 286 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study

Tsutomu Takeuchi, Carter Thorne, George Karpouzas et al. · Annals of the Rheumatic Diseases · 2017 · 66 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis

Wolfgang Schmidt, Bhaskar Dasgupta, Raashid Luqmani et al. · Rheumatology and Therapy · 2020 · 63 citations · Full text

Life Sciences, Clinical Sciences, Pharmacotherapy +13

Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study

Peter C. Taylor, Michael Schiff, Qingmin Wang et al. · Annals of the Rheumatic Diseases · 2018 · 28 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

John D. Isaacs, Sarah Brockbank, Ayako Wakatsuki Pedersen et al. · Scientific Data · 2022 · 25 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17